Literature DB >> 16109773

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

Yang Du1, Nancy A Jenkins, Neal G Copeland.   

Abstract

Retroviruses can induce hematopoietic disease via insertional mutagenesis of cancer genes and provide valuable molecular tags for cancer gene discovery. Here we show that insertional mutagenesis can also identify genes that promote the immortalization of hematopoietic cells, which normally have only limited self-renewal. Transduction of mouse bone marrow cells with replication-incompetent murine stem cell virus (MSCV) expressing only neo, followed by serial passage in liquid culture containing stem cell factor (SCF) and interleukin-3 (IL-3), produced immortalized immature myeloid cell lines with neutrophil and macrophage differentiation potential in about 50% of the infected cultures. More than half of the lines have MSCV insertions at Evi1 or Prdm16. These loci encode transcription factor homologs and are validated human myeloid leukemia genes. Integrations are located in intron 1 or 2, where they promote expression of truncated proteins lacking the PRDI-BF1-RIZ1 homologous (PR) domain, similar to what is observed in human leukemias with EVI1 or PRDM16 mutations. Evi1 overexpression alone appears sufficient to immortalize immature myeloid cells and does not seem to require any other cooperating mutations. Genes identified by insertional mutagenesis by their nature could also be involved in immortalization of leukemic stem cells, and thus represent attractive drug targets for treating cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109773      PMCID: PMC1895096          DOI: 10.1182/blood-2005-03-1113

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Myelodysplastic syndromes: recent advances.

Authors:  E P Alessandrino; S Amadori; M Cazzola; F Locatelli; C Mecucci; E Morra; G Saglio; G Visani; S Tura
Journal:  Haematologica       Date:  2001-11       Impact factor: 9.941

3.  Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Authors:  S R Cherry; D Biniszkiewicz; L van Parijs; D Baltimore; R Jaenisch
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.

Authors:  C Cobaleda; N Gutiérrez-Cianca; J Pérez-Losada; T Flores; R García-Sanz; M González; I Sánchez-García
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

5.  Transposition and gene disruption in the male germline of the mouse.

Authors:  A J Dupuy; S Fritz; D A Largaespada
Journal:  Genesis       Date:  2001-06       Impact factor: 2.487

Review 6.  Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Authors:  Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

Review 7.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

8.  A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.

Authors:  N Mochizuki; S Shimizu; T Nagasawa; H Tanaka; M Taniwaki; J Yokota; K Morishita
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

9.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.

Authors:  B Varnum-Finney; L Xu; C Brashem-Stein; C Nourigat; D Flowers; S Bakkour; W S Pear; I D Bernstein
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

10.  BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.

Authors:  S C Kogan; D E Brown; D B Shultz; B T Truong; V Lallemand-Breitenbach; M C Guillemin; E Lagasse; I L Weissman; J M Bishop
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  90 in total

Review 1.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

2.  Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Authors:  Annette Deichmann; Salima Hacein-Bey-Abina; Manfred Schmidt; Alexandrine Garrigue; Martijn H Brugman; Jingqiong Hu; Hanno Glimm; Gabor Gyapay; Bernard Prum; Christopher C Fraser; Nicolas Fischer; Kerstin Schwarzwaelder; Maria-Luise Siegler; Dick de Ridder; Karin Pike-Overzet; Steven J Howe; Adrian J Thrasher; Gerard Wagemaker; Ulrich Abel; Frank J T Staal; Eric Delabesse; Jean-Luc Villeval; Bruce Aronow; Christophe Hue; Claudia Prinz; Manuela Wissler; Chuck Klanke; Jean Weissenbach; Ian Alexander; Alain Fischer; Christof von Kalle; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

4.  Overexpression of PRDM16 in the presence and absence of the RUNX1/PRDM16 fusion gene in myeloid leukemias.

Authors:  Sawcène Hazourli; Pierre Chagnon; Martin Sauvageau; Raouf Fetni; Lambert Busque; Josée Hébert
Journal:  Genes Chromosomes Cancer       Date:  2006-11       Impact factor: 5.006

5.  Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.

Authors:  Takeshi Suzuki; Ken-ichi Minehata; Keiko Akagi; Nancy A Jenkins; Neal G Copeland
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

6.  Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque.

Authors:  Ruth Seggewiss; Stefania Pittaluga; Rima L Adler; F Javier Guenaga; Cole Ferguson; Ingo H Pilz; Byoung Ryu; Brian P Sorrentino; W Scott Young; Robert E Donahue; Christof von Kalle; Arthur W Nienhuis; Cynthia E Dunbar
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

7.  Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.

Authors:  Olga S Kustikova; Hartmut Geiger; Zhixiong Li; Martijn H Brugman; Stuart M Chambers; Chad A Shaw; Karin Pike-Overzet; Dick de Ridder; Frank J T Staal; Gottfried von Keudell; Kerstin Cornils; Kalpana Jekumar Nattamai; Ute Modlich; Gerard Wagemaker; Margaret A Goodell; Boris Fehse; Christopher Baum
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

8.  Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells.

Authors:  Sonia Cellot; Jana Krosl; Jalila Chagraoui; Sylvain Meloche; R Keith Humphries; Guy Sauvageau
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

9.  An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.

Authors:  Byoung Y Ryu; Marguerite V Evans-Galea; John T Gray; David M Bodine; Derek A Persons; Arthur W Nienhuis
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

10.  Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.

Authors:  Weili Chen; Ashish R Kumar; Wendy A Hudson; Quanzhi Li; Baolin Wu; Rodney A Staggs; Erik A Lund; Thien N Sam; John H Kersey
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.